Melissa W. Taggart, M.D.
Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div
About Dr. Melissa W. Taggart
I am a board certified anatomic and clinical pathologist with subspecialty training and expertise in gastrointestinal neoplasia. In addition to my clinical duties as a gastrointestinal pathologist at a tertiary care cancer center, I have been involved in a number collaborative endeavors with clinicians (oncologists, gastroenterologists, radiologists, and surgeons), as well as histomorphologic studies. Many of my studies have focused on colorectal adenocarcinoma, including those evaluating treatment response and hereditary colorectal cancer syndromes such as Lynch Syndrome (LS) and Familial Adenomatous Polyposis (FAP). Currently, I provide pathology support (tissue review in both human and murine samples) for a number of trials and studies including those investigating biomarkers for the activity of Naproxen in LS patients, genomic findings in colorectal adenomas in FAP patients, a phase II/III trial evaluating selective use of combined modality chemoradiation in locally advanced rectal cancer patients, and molecular determinants of response to preoperative therapy in patients with locally advanced colorectal adenocarcinoma. With these studies, we hope to further personalize treatment for patients with colorectal carcinoma, determine biomarkers for chemoradiation response for and/or resistance to current treatment modalities, and discover targeted biomarkers for prevention in patients with hereditary colonic carcinoma syndromes.
Read More
Present Title & Affiliation
Primary Appointment
Professor, Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2001 | Louisiana State University School of Medicine, New Orleans, Louisiana, US, MD |
| 1997 | University of New Orleans, New Orleans, Louisiana, US, Biological Sciences, BS |
| 1996 | University of New Orleans, New Orleans, Louisiana, US, Chemistry, BA |
Postgraduate Training
| 2007-2008 | Clinical Fellowship, Gastrointestinal Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2006-2007 | Clinical Fellowship, Surgical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2001-2006 | Clinical Residency, Anatomic Pathology/Clinical Pathology, Louisiana State University Health Sciences Center, New Orleans, Louisiana |
Licenses & Certifications
| 2008 | Texas State Medical Licensure |
| 2006 | American Board of Pathology, Anatomic and Clinical Pathology, Recertification Date: 12/2016 |
Experience & Service
Faculty Academic Appointments
Associate Professor, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - 2022
Assistant Professor, Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009 - 2016
Administrative Appointments/Responsibilities
Program Site Director, Department of Pathology and Laboratory Medicine Medical Student Rotation Program, University of Texas School of Medicine at Houston PATH 4011, Houston, TX, 2021 - 2023
Director, Department of Anatomic Pathology, MDACC, Houston, TX, 2020 - 2025
Assistant Executive Director, Pathology and Laboratory Medicine, MDACC Physicians Network, 5% salary support, Houston, TX, 2020 - 2023
Other Professional Positions
Clinical team member, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2023
Clinical Consultant, Gastrointestinal Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2014 - 2023
Louisiana Air National Guard, Avionics Technician, Belle Chase, Louisiana, Reservist, Louisiana Air National Guard, 1992 - 1998
Intramural Institutional Committee Activities
Collaborator, GI Spore: Lynch, The University of Texas MD Anderson Cancer Center, 2024 - Present
Member, Gastrointestinal and Liver Pathology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, General Surgical Pathology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2024
Member, General Surgical Pathology Fellowship Clinical Competency Committee, The University of Texas MD Anderson Cancer Center, 2020 - 2024
Member, Gastrointestinal and Liver Pathology Fellowship Program Evaluation Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Reviewer, Colon and Rectal Cancer Algorithms, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Colorectal Moonshot - Young Onset Rectal Cancer, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present
Member, Pathology Rare Tumors Working Group, The University of Texas MD Anderson Cancer Center, 2016 - 2023
Member, Cancer of Unknown Primary Working Group, The University of Texas MD Anderson Cancer Center, 2015 - Present
Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2014 - 2023
Program planning committee member, Peritoneal surface Malignancy Multidisciplinary Conference, The University of Texas MD Anderson Cancer Center, 2010 - 2024
Member, Graduate Medical Education Committee, Louisiana State University Health Sciences Center, 2002 - 2006
Extramural Institutional Committee Activities
Member, Colorectal Cancer Disease Focused Panel, Society of Abdominal Imaging, 2022 - 2023
Honors & Awards
| 2020 - 2021 | Nominee: Mentorship Category, Department of Pathology Anatomical, Division of Pathology and Laboratory Medicine Faculty Award |
| 2019 - 2020 | Mentored Trainee Research Award Recipient: Evaluation of mast cell concentrations and by-products in Hepatic Fibrosis in a mouse model and in Humans with Varying Stages of Hepatic Fibrosis |
| 2018 - 2019 | Mentored Trainee Research Award Recipient: Evaluation for Isochromosome 12p i(12p) by Fluorescence In-Situ Hybridization in Primary Carcinomas of the Gastrointestinal Tract with Primitive Features |
| 2018 | MDACC Wall of Science: Immune Profiling of Premalignant Lesions in Patients with Lynch Syndrome. JAMA Oncol. 2018 Aug 1;4 (8):1085-1092 |
| 2013 | Certificate of Merit: Appendiceal Cancer: An Update on Pathology, Imaging and Therapy; Education Exhibit, Radiological Society of North American |
| 2013 | Certificate of Merit: Atypical Imaging Presentations of Focal Nodular Hyperplasia with Radiologic Pathologic Correlation; Education Exhibit, Radiological Society of North American |
| 2012 | Certificate of Merit: Strengths and Limitations of Extravasation and Liver Specific Contrast Agents in the Evaluation of Liver Lesions; Education Exhibit, Radiological Society of North American |
| 2003 | Nominee: Resident of the Year, Medical Center of Louisiana in New Orleans, Louisiana State University Health Science Center |
| 1998 | Honorable Discharge, Louisiana Air National Guard-Belle Chase, Louisiana |
| 1997 | Airman of the Year, State of Louisiana, State of Louisiana, Louisiana Air National Guard-Belle Chase, Louisiana |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2021. M.D. Anderson Cancer Network Gastrointestinal Virtual Integration Retreat. Panelist. M.D. Anderson Cancer Center. Houston, TX, US.
- 2020. M.D. Anderson Cancer Network Gastrointestinal Virtual Integration Retreat Agenda. Panelist. M.D. Anderson Cancer Center. Houston, TX, US.
- 2019. MDACC Pathology Overview and Pathology Breakout Session Liaison, MD Anderson Cancer Network Gastrointestinal Integration Retreat Agenda. M.D. Anderson Cancer Center. Houston, TX, US.
- 2016. Colon Polyps-Beyond the Adenoma. Invited. MDACC Diagnostic Course. Houston, TX, US.
- 2014. Basics of Pathology. Invited. Physician Assistant Continuing Education Lecture Series. Houston, Texas, US.
- 2013. Pancreatic Tumors. Invited. Pancreaticobiliary Tumor Conference. Houston, Texas, US.
- 2010. IHC Evaluation of Suspected GI Cancers and Unknown Primaries. Invited. Multidisciplinary Colorectal Cancer Conference. Houston, Texas, US.
- 2009. Goblet Carcinoid Tumors. Invited. Houston, Texas, US.
National Presentations
- 2023. The Surgical Pathologist’s Role in Biomarker Testing for Colorectal Cancer. Invited. American Society for Clinical Pathology Annual Meeting. Long Beach, CA, US.
- 2023. Accurate Assessment for Colorectal Cancer Diagnosis. Invited. American Society for Clinical Pathology Annual Meeting. Long Beach, CA, US.
- 2019. Colonic Polyps – the Ordinary and the Unusual. Invited. The Napa Valley Surgpath Conference – Updates in Surgical Pathology. Napa, CA, US.
- 2019. “Common” Tumors of the Appendix. Invited. The Napa Valley Surgpath Conference – Updates in Surgical Pathology. Napa, CA, US.
- 2019. Neuroendocrine Tumors of the Gastrointestinal Tract: Issues and Updates. Invited. The Napa Valley Surgpath Conference – Updates in Surgical Pathology. Napa, CA, US.
- 2018. Colorectal Neoplasms – AJCC Staging with 2017 Edition Updates. Invited. National Cancer Registrars Association 44th Annual Educational Conference. New Orleans, LA, US.
- 2017. Pathologic Findings after Surgical Resection in Metastatic Colon Cancer; Medical Education Program on CRC - GI Multidisciplinary Cancer Management. Invited. MDACC Global Academic Programs. Houston, TX, US.
- 2015. Pathologic Findings after Surgical Resection in Metastatic Colon Cancer; Medical Education Program on CRC - GI Multidisciplinary Cancer Management. Invited. MDACC Global Academic Programs. Houston, TX, US.
- 2014. Pathologic Findings after Surgical Resection in Metastatic Colon Cancer; Medical Education Program on CRC - GI Multidisciplinary Cancer Management. Invited. MDACC Global Academic Programs. Houston, TX, US.
- 2013. Duplication of Molecular Testing at a Tertiary Care Oncology Center. Poster. United States and Canadian Academy of Pathology Annual Meeting. Baltimore, MD, US.
- 2013. Esophageal Squamous Dysplasia – Clinical Associations and Follow-up. Poster. Digestive Disease Week. Orlando, FL, US.
- 2012. Serrated Polyps of the Extracolonic Gastrointestinal Tract: Histologic Findings and Genetic Alterations. Poster. United States and Canadian Academy of Pathology Annual Meeting. Vancouver, CA.
- 2011. What the Blood Compartment Can Teach us About Colorectal Cancer: Circulating Tumor Cells and DNA; Changing Paradigms in Cancer Treatment and Patient Management. Invited. Physicians Network Symposium. San Francisco, CA, US.
- 2011. Immunohistochemistry, PCR, and Genomics for Colorectal Pathology: When, Why, and For Whom? Changing Paradigms in Cancer Treatment and Patient Management. Invited. Physicians Network Symposium. San Francisco, CA, US.
- 2010. Esophageal Leukoplakia: Risk Factors and Relationship to Squamous Neoplasia. Poster. United States and Canadian Academy of Pathology Annual Meeting. Washington, DC, US.
- 2008. Appendiceal Mixed Carcinoid-Adenocarcinomas Share Better Prognosis Associated with Goblet Cell Carcinoid Tumors. Poster. United States and Canadian Academy of Pathology Annual Meeting. Denver, CO, US.
- 2007. Nucleolar Expression of Catalytic Subunit of Human Telomerase Reverse Transcriptase (Htert) Is Associated with Better Survival in Patients with Stage III Colon Cancer. Poster. United States and Canadian Academy of Pathology Annual Meeting. San Diego, CA, US.
International Presentations
- 2024. Evolving concepts of gastroenteropancreatic neuroendocrine neoplasms. Invited. Advances in Surgical Pathology, 55th Professor Janez Plecnik Memorial Meeting. Ljubljana, SI.
- 2024. Case presentations in gastrointestinal pathology. Invited. Advances in Surgical Pathology, 55th Professor Janez Plecnik Memorial Meeting. Ljubljana, SI.
- 2024. Consensus and controversy in appendiceal lesions. Invited. Advances in Surgical Pathology, 55th Professor Janez Plecnik Memorial Meeting. Ljubljana, SI.
- 2024. Microsatellite Instability in Colorectal Adenocarcinoma (virtual presentation). Invited. Project ECHO, US.
- 2023. Carcinoma of Anorectum: Case Studies. Invited. 6th Annual Conference of Indian Society for Gastrointestinal and Abdominal Radiology, IN.
- 2022. Multidisciplinary Case Discussion (virtual conference). Invited. MD Anderson International Symposium on the Surgical Management of Rectal Cancer, US.
- 2021. Multidisciplinary Case Discussion (virtual conference). Invited. MD Anderson International Symposium on the Surgical Management of Rectal Cancer, US.
- 2020. Challenges in Appendiceal Tumors. Invited. EuroPMP Pathology Workshop (virtual conference). Basingstoke, GB.
- 2019. Colonic Polyps – the Ordinary and the Unusual. Invited. New and Evolving Concepts in Surgical Pathology. Naturaliste, AU.
- 2019. “Common” Uncommon Tumors of the Appendix – Updates and Issues. Invited. New and Evolving Concepts in Surgical Pathology. Naturaliste, AU.
- 2019. Appendiceal Neoplasms – Updates and Issues. Invited. 2nd Copenhagen Surgical Pathology Update 2019. Copenhagen, DK.
- 2019. Colonic Polyposis – Considerations Beyond the Slide. Invited. 2nd Copenhagen Surgical Pathology Update 2019. Copenhagen, DK.
- 2019. Challenging Appendiceal Cases. Invited. International CME in Pathology – Histopathology and Cytopathology. Goa, IN.
- 2019. Updates and Issues in Appendiceal Tumors. Invited. International CME in Pathology – Histopathology and Cytopathology. Goa, IN.
- 2019. Colorectal Adenocarcinoma in the Young Patient: Hereditary Conditions, Ancillary Testing, and Changing Demographics. Invited. International CME in Pathology – Histopathology and Cytopathology. Goa, IN.
- 2019. Neuroendocrine Tumors of the Gastrointestinal Tract. Invited. International CME in Pathology – Histopathology and Cytopathology. Goa, IN.
- 2018. Updates and Issues in Appendiceal Tumors. Invited. 2nd Pathology Meeting MDACC Advances in Molecular and Diagnostic Pathology. Madrid, ES.
- 2018. Slide Seminar – Gastrointestinal Case. Invited. 2nd Pathology Meeting MDACC Advances in Molecular and Diagnostic Pathology. Madrid, ES.
- 2018. Goblet Cell Carcinoid: Recent Data from a Complex Entity. Impact on the Treatment Strategy. Invited. 11th International Workshop on Peritoneal Surface Malignancy. Paris, FR.
- 2018. Colorectal Carcinoma: Hereditary Conditions, Ancillary Testing and Changing Demographics. Invited. 3rd Annual Course of Surgical Pathology "Dr. Hector Santiago Payan. Mexico City, MX.
- 2018. Updates in Appendiceal Mucinous Neoplasms. Invited. 3rd Annual Course of Surgical Pathology "Dr. Hector Santiago Payan. Mexico City, MX.
- 2017. Serrated Colonic Lesions. Invited. Beijing, CN.
- 2017. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei Moving Towards Consensus. Invited. Beijing, CN.
- 2017. Appendiceal Mucinous Neoplasms & Pseudomyxoma Peritonei Moving Towards Consensus. Invited. Beijing, CN.
- 2017. Serrated Colonic Lesions. Invited. Beijing, CN.
- 2016. Case Studies in GI Pathology. Invited. Problems in Tumor Pathology. Manchester, GB.
- 2016. Appendiceal Neoplasms: Controversies and Updates. Invited. Problems in Tumor Pathology. Manchester, GB.
- 2016. Gastrointestinal Neuroendocrine Tumors-Evolving Concepts. Invited. Problems in Tumor Pathology. Manchester, GB.
Formal Peers
- 2024. CRC Biomarkers and the Impact of Patients' Lives. Houston, Texas, US.
- 2023. Appendiceal Pathology. Palm Springs, CA, US.
- 2023. Neuroendocrine Proliferations/Neoplasms. Palm Springs, CA, US.
- 2023. Appendiceal Mucinous Neoplasms - Challenges in Practice (virtual lecture). Sacramento, California, US.
- 2017. Interdisciplinary Approaches to Personalizing Immunotherapy in Metastatic Immunotherapy in Metastatic CRC using Advances in Molecular Markers. Houston, TX, US.
Grant & Contract Support
| Date: | 2025 - 2029 |
| Title: | Developing A Platform for Prospective Clinical Trials Appendiceal Cancer |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RP250323 |
| Date: | 2024 - 2029 |
| Title: | Integrated Clinical and Preclinical Approach for the Development of Effective Therapy in the Drug Resistant GNAS/KRAS Subtype of Appendiceal Adenocarcinoma |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00021749 |
| Date: | 2024 - 2029 |
| Title: | MD Anderson Cancer Center SPORE in Gastrointestinal Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00020524 |
| Date: | 2024 - 2029 |
| Title: | Assessment of Immune Responses to Neoantigen Vaccination in Lynch Syndrome |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | FP00021341 |
| Date: | 2024 - 2027 |
| Title: | Identifying Tumor Specific Vulnerabilities in Appendiceal Adenocarcinoma: A Systems Approach |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | RFA R-24.1-IIRA |
| Date: | 2023 - 2025 |
| Title: | A Comprehensive Approach for the Development of Novel Chemotherapy Treatments for Appendiceal Adenocarcinoma |
| Funding Source: | Appendix Cancer Pseudomyxoma Peritonei Research Foundation |
| Role: | Collaborator |
| ID: | FP00018762 |
| Date: | 2023 - 2026 |
| Title: | Identifying Tumor Specific Vulnerabilities in Appendiceal Adenocarcinoma: A Systems Approach |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| ID: | FP16720/RFA-R-23.1-IIRA |
| Date: | 2020 - 2026 |
| Title: | Cancer Immune-Interception for Lynch Syndrome |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA257375-01 |
| Date: | 2020 - 2022 |
| Title: | Magnetic nanoparticles for Precision Surgical Oncology and Radiotherapy |
| Funding Source: | Ferronova Pty Ltd |
| Role: | Collaborator |
| ID: | FP00010703 |
| Date: | 2018 - 2023 |
| Title: | Neoantigen Vaccination for Lynch Syndrome Immunoprevention |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 5U01CA233056-04 |
| Date: | 2018 - Present |
| Title: | Organ Preservation with AcTive Surveillance after ChemOradiation in Rectal Cancer (OPTION) |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 2016-0549 |
| Date: | 2017 - 2022 |
| Title: | A Phase I Study of Talimogene Laherparepvec (Talimogene Laherparepvec) With Neoadjuvant Chemotherapy and Radiation in Adenocarcinoma of the Rectum Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | NCT03300544 |
| Date: | 2017 - 2022 |
| Title: | Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 5R01CA219463-05 |
| Date: | 2017 - 2019 |
| Title: | Uncovering Gene Expression Differences between Benign and Premalignant Colorectal Polyps |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 1R21 CA208461-01A1 |
| Date: | 2014 - 2020 |
| Title: | A Phase 1b Biomarker Trial of Naproxen in Patient at Risk for DNA Mismatch Repair Deficient Colorectal Cancer |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | 2013-0698 |
| Date: | 2013 - Present |
| Title: | A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patient Undergoing Low Anterior Resection with Total Mesorectal Excision |
| Funding Source: | NIH/NCI |
| Role: | Collaborator |
| ID: | N1048 |
| Date: | 2010 - 2016 |
| Title: | An Open-Label, Multicenter, Randomized, Phase 3 of S-1 and Cisplatin Compared to 5-FU and Cisplatin in Patients with Metastatic Diffuse Gastric Cancer Previously Untreated with Chemotherapy |
| Funding Source: | Taiho Pharmaceutical Inc. USA Food and Drug Administration |
| Role: | Collaborator |
| ID: | LS2011-00034580 |
Selected Publications
Peer-Reviewed Articles
- Seldomridge, AN, White, MG, Scally, CP, Royal, RE, Routbort, MJ, Iorgulescu, JB, Overman, MJ, Lee, SM, Foo, WC, Taggart, MW, Song, Y, Mansfield, PF, Fournier, KF, Shen, JY, Helmink, BA. ASO Visual Abstract. Annals of surgical oncology 33(3):2439-2440, 2026. e-Pub 2026. PMID: 41366166.
- Song, Y, Allam, J, Beaty, K, Willett, A, Taggart, MW, Malpica, A, Royal, RE, Mansfield, PF, Huey, RW, Raghav, KS, Fournier, KF, Helmink, BA. Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy following neoadjuvant systemic therapy for high-volume peritoneal mesothelioma. Surgical Oncology Insight 3(1), 2026. e-Pub 2026.
- Seldomridge, AN, White, MG, Scally, CP, Royal, RE, Routbort, MJ, Iorgulescu, J, Overman, MJ, Lee, SM, Foo, WC, Taggart, MW, Song, Y, Mansfield, PF, Fournier, KF, Shen, JY, Helmink, BA. Clinicopathologic and Molecular Characteristics of High-Grade Appendiceal Mucinous Neoplasms. Annals of surgical oncology 33(3):2376-2387, 2026. e-Pub 2026. PMID: 41225239.
- Bowen, CM, Duzagac, F, Martel-Martel, A, Reyes-Uribe, L, Zaheer, M, Thompson, J, Deng, N, Sinha, R, Mazumdar, S, Taggart, MW, Jain, A, Tosti, E, Edelmann, W, Sinha, K, Vilar Sanchez, E. Inhibition of histone methyltransferase EZH2 for immune interception of colorectal cancer in Lynch syndrome. JCI Insight 10(6), 2025. e-Pub 2025. PMID: 39946195.
- Ito, I, Pattalachinti, V, Yousef, A, Chowdhury, S, Fanaeian, M, Haque, EU, Gunes, BB, Yousef, M, Salle, ER, Zeineddine, MA, Ji, S, Li, R, Wang, W, Helmink, BA, Taggart, MW, White, MG, Fournier, KF, Fowlkes, NW, Shen, JY. Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma. ESMO Gastrointestinal Oncology 7, 2025. e-Pub 2025. PMID: 41069644.
- White, MG, Zeineddine, MA, Fallon, EA, Zeineddine, F, Dansby, J, Chowdhury, S, Hornstein, N, Yousef, A, Yousef, M, Bhutiani, N, Gu, Y, Kee, BK, Dasari, NV, Overman, MJ, Raghav, KS, Kopetz, S, Uppal, A, Taggart, MW, Newhook, TE, Fournier, KF, Helmink, BA, Drusbosky, L, Shen, JY. The Landscape of ctDNA in Appendiceal Adenocarcinoma. Clinical Cancer Research 31(3):551-560, 2025. e-Pub 2025. PMID: 39679931.
- Bhutiani N, Peacock O, Uppal A, Hu CY, Bednarski BK, Taggart MW, Dasari A, Morris VK, Kaur H, Kopetz S, Holliday EB, Das P, You YN, Chang GJ. The prognostic impact of tumor deposits in colorectal cancer: More than just N1c. Cancer 130(23):4052-4060, 2024. e-Pub 2024. PMID: 39306694.
- van Geffen EGM, Sluckin TC, Hazen SJA, Horsthuis K, Intven M, van Dieren S, Beets G, Lange MM, Taggart MW, Beets-Tan RGH, Marijnen CAM, Konishi T, Tanis PJ, Kusters M. Optimised treatment of patients with enlarged lateral lymph nodes in rectal cancer: protocol of an international, multicentre, prospective registration study after extensive multidisciplinary training (LaNoReC). BMJ Open 14(10):e083225, 2024. e-Pub 2024. PMID: 39414276.
- Kaur H, Gabriel H, Awiwi MO, Maheshwari E, Lopes Vendrami C, Konishi T, Taggart MW, Magnetta M, Kelahan LC, Lee S. Anatomic Basis of Rectal Cancer Staging: Clarifying Controversies and Misconceptions. Radiographics 44(7):e230203, 2024. e-Pub 2024. PMID: 38900679.
- Meuser E, Chang K, Walters A, Hurley JJ, West HD, Perry I, Mort M, Reyes-Uribe L, Truscott R, Jones N, Lawrence R, Jenkins G, Giles P, Dolwani S, Al-Sarireh B, Hawkes N, Short E, Williams GT, Taggart MW, Luetchford K, Lynch PM, Terlouw D, Nielsen M, Walton SJ, Latchford A, Clark SK, Sampson JR, Vilar E, Thomas LE. PIGA Mutations and Glycosylphosphatidylinositol Anchor Dysregulation in Polyposis-Associated Duodenal Tumorigenesis. Mol Cancer Res 22(6):515-523, 2024. e-Pub 2024. PMID: 38546397.
- Hornstein NJ, Zeineddine MA, Gunes BB, Pellatt AJ, Knafl M, Zhu H, Willett AF, Yousef A, Liu S, Sun R, Futreal A, Woodman SE, Taggart MW, Overman MJ, Halperin DM, Raghav KP, Shen JP. Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal Adenocarcinoma. Cancer Res Commun 4(5):1363-1368, 2024. e-Pub 2024. PMID: 38709066.
- Bolivar AM, Duzagac F, Deng N, Reyes-Uribe L, Chang K, Wu W, Bowen CM, Taggart MW, Thirumurthi S, Lynch PM, You YN, Rodriguez-Pascual J, Lipkin SM, Kopetz S, Scheet P, Lizee GA, Reuben A, Sinha KM, Vilar E. Genomic Landscape of Lynch Syndrome Colorectal Neoplasia Identifies Shared Mutated Neoantigens for Immunoprevention. Gastroenterology 166(5):787-801.e11, 2024. e-Pub 2024. PMID: 38244726.
- Pattalachinti VK, Ito I, Chowdhury S, Yousef A, Gu Y, Gunes BB, Salle ER, Taggart MW, Fournier K, Fowlkes NW, Shen JP. Peritoneal Microenvironment Promotes Appendiceal Adenocarcinoma Growth: A Multi-omics Approach Using Patient-Derived Xenografts. Mol Cancer Res 22(4):329-336, 2024. e-Pub 2024. PMID: 38226984.
- Yousef A, Yousef M, Zeineddine MA, More A, Fanaeian M, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine FA, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally CP, Kee B, Kopetz S, Goldstein D, Strach M, Williamson A, Aziz O, Barriuso J, Uppal A, White MG, Helmink B, Fournier KF, Raghav KP, Taggart MW, Overman MJ, Shen JP. Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma. JAMA Netw Open 7(2):e240260, 2024. e-Pub 2024. PMID: 38416491.
- Bhutiani N, Grotz TE, Concors SJ, White MG, Helmink BA, Raghav KP, Taggart MW, Beaty KA, Royal RE, Overman MJ, Matamoros A, Scally CP, Rafeeq S, Mansfield PF, Fournier KF. Repeat Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Appendiceal Adenocarcinoma: A Viable Treatment Strategy with Demonstrable Benefit. Ann Surg Oncol 31(1):614-621, 2024. e-Pub 2024. PMID: 37872456.
- Stanietzky N, Bednarski B, Shafer A, Taggart MW, Peacock O, Vikram R. Rectal Adenocarcinoma Presenting as a Cervical Mass: A Case Report. Am J Case Rep 24:e941884, 2023. e-Pub 2023. PMID: 38011075.
- Dhingra S, Taggart MW, Foo WC, Rashid A, Heredia MLM, May SB, Van Buren G 2nd, Fisher WE, Wang H. Interobserver Variability and Challenges in Intraoperative Frozen Section Evaluation of Pancreatic Margins in Pancreatectomy Specimens. Ann Clin Lab Sci 53(6):847-860, 2023. e-Pub 2023. PMID: 38182140.
- Yousef A, Yousef M, Zeineddine M, More A, Chowdhury S, Knafl M, Edelkamp P, Ito I, Gu Y, Pattalachinti V, Naini ZA, Zeineddine F, Peterson J, Alfaro K, Foo WC, Jin J, Bhutiani N, Higbie V, Scally C, Kee B, Kopetz S, Goldstein D, Uppal A, White MG, Helmink B, Fournier K, Raghav K, Taggart MW, Overman MJ, Shen JP. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma. medRxiv, 2023. e-Pub 2023. PMID: 37745596.
- Erstad DJ, Robinson KA, Beaty K, Rafeeq S, Chiang YJ, Raghav K, Shen JP, Overman MJ, Foo WC, Taggart MW, Mansfield PF, Royal RE, Fournier KF, Scally CP. Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal neoplasms. Langenbecks Arch Surg 408(1):110, 2023. e-Pub 2023. PMID: 36853519.
- White MG, Bhutiani N, Helmink BA, Taggart MW, Foo WC, Mansfield PF, Fournier KF, Scally CP. Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Ann Surg Oncol 30(13):8138-8143, 2023. e-Pub 2023. PMID: 37702905.
- Shen JP, Yousef AM, Zeineddine FA, Zeineddine MA, Tidwell RS, Beaty KA, Scofield LC, Rafeeq S, Hornstein N, Lano E, Eng C, Matamoros A, Foo WC, Uppal A, Scally C, Mansfield P, Taggart MW, Raghav KP, Overman MJ, Fournier K. Efficacy of Systemic Chemotherapy in Patients With Low-grade Mucinous Appendiceal Adenocarcinoma: A Randomized Crossover Trial. JAMA Netw Open 6(6):e2316161, 2023. e-Pub 2023. PMID: 37261831.
- Del Carmen G, Reyes-Uribe L, Goyco D, Evans K, Bowen CM, Kinnison JL, Sepeda VO, Weber DM, Moskowitz J, Mork ME, Thirumurthi S, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN, Vilar E. Colorectal surveillance outcomes from an institutional longitudinal cohort of lynch syndrome carriers. Front Oncol 13:1146825, 2023. e-Pub 2023. PMID: 37168379.
- Peacock O, Manisundaram N, Dibrito SR, Kim Y, Hu CY, Bednarski BK, Konishi T, Stanietzky N, Vikram R, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Magnetic Resonance Imaging Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection in Rectal Cancer After Total Neoadjuvant Therapy (TNT). Ann Surg 276(4):654-664, 2022. e-Pub 2022. PMID: 35837891.
- Erstad DJ, Dasari A, Taggart MW, Kaur H, Konishi T, Bednarski BK, Chang GJ. Prognosis for Poorly Differentiated, High-Grade Rectal Neuroendocrine Carcinomas. Ann Surg Oncol 29(4):2539-2548, 2022. e-Pub 2022. PMID: 34787737.
- Ozirmak Lermi N, Gray SB, Bowen CM, Reyes-Uribe L, Dray BK, Deng N, Harris RA, Raveendran M, Benavides F, Hodo CL, Taggart MW, Colbert Maresso K, Sinha KM, Rogers J, Vilar E. Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancer. PLoS Genet 18(4):e1010163, 2022. e-Pub 2022. PMID: 35446842.
- Uppal A, Helmink B, Grotz TE, Konishi T, Fournier KF, Nguyen S, Taggart MW, Shen JP, Bednarski BK, You YN, Chang GJ. What is the Risk for Peritoneal Metastases and Survival Afterwards in T4 Colon Cancers?. Ann Surg Oncol 29(7):4224-4233, 2022. e-Pub 2022. PMID: 35307803.
- Kothari A, White MG, Peacock O, Kaur H, Palmquist SM, You N, Taggart MW, Salem U, Overman M, Kopetz S, Chang GJ. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer. Br J Surg 109(6):489-492, 2022. e-Pub 2022. PMID: 35576377.
- Ibarra Rovira J, Thirumurthi S, Taggart MW, Yilmaz B, Lin H, Zhong LL, Ejezie CL, Akhmedzhanov FO, Zarifa A, Leung CH, Hong DS, Vikram R. Role of Abdominal and Pelvic CT Scans in Diagnosis of Patients with Immunotherapy-Induced Colitis. J Immunother Precis Oncol 5(2):32-36, 2022. e-Pub 2022. PMID: 35664090.
- Bowen CM, Walter L, Borras E, Wu W, Ozcan Z, Chang K, Bommi PV, Taggart MW, Thirumurthi S, Lynch PM, Reyes-Uribe L, Scheet PA, Sinha KM, Vilar E. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis. Cancer Prev Res (Phila) 14(9):851-862, 2021. e-Pub 2021. PMID: 34266857.
- Virarkar M, Morani AC, Taggart MW, Bhosale P. Liver Fibrosis Assessment. Semin Ultrasound CT MR 42(4):381-389, 2021. e-Pub 2021. PMID: 34130850.
- Bommi PV, Bowen CM, Reyes-Uribe L, Wu W, Katayama H, Rocha P, Parra ER, Francisco-Cruz A, Ozcan Z, Tosti E, Willis JA, Wu H, Taggart MW, Burks JK, Lynch PM, Edelmann W, Scheet PA, Wistuba II, Sinha KM, Hanash SM, Vilar E. The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells. Cancer Res 81(10):2760-2773, 2021. e-Pub 2021. PMID: 34003775.
- Reyes-Uribe L, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuelta M, Chang K, You YN, Kopelovich L, Wistuba II, Lee JJ, Sei S, Shoemaker RH, Szabo E, Richmond E, Umar A, Perloff M, Brown PH, Lipkin SM, Vilar E. Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal mucosa. Gut 70(3):555-566, 2021. e-Pub 2021. PMID: 32641470.
- Arumov A, Liyanage PY, Trabolsi A, Roberts ER, Li L, Ferreira BCLB, Gao Z, Ban Y, Newsam AD, Taggart MW, Vega F, Bilbao D, Leblanc RM, Schatz JH. Optimized Doxorubicin Chemotherapy for Diffuse Large B-cell Lymphoma Exploits Nanocarrier Delivery to Transferrin Receptors. Cancer Res 81(3):763-775, 2021. e-Pub 2021. PMID: 33177062.
- Peacock O, Limvorapitak T, Bednarski BK, Kaur H, Taggart MW, Dasari A, Holliday EB, Minsky BD, You YN, Chang GJ. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: a Western perspective. Colorectal Dis 22(12):2049-2056, 2020. e-Pub 2020. PMID: 32892473.
- Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Tillman MM, Kaur H, Taggart MW, Dasari A, Holliday EB, You YN, Chang GJ. Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes. Br J Surg 107(12):1552-1557, 2020. e-Pub 2020. PMID: 32996597.
- Raghav K, Shen JP, Jacome AA, Guerra JL, Scally CP, Taggart MW, Foo WC, Matamoros A, Shaw KR, Fournier K, Overman MJ, Eng C. Integrated clinico-molecular profiling of appendiceal adenocarcinoma reveals a unique grade-driven entity distinct from colorectal cancer. Br J Cancer 123(8):1262-1270, 2020. e-Pub 2020. PMID: 32733093.
- Khalil MF, Taggart MW, Khazai L. Lamellated mucin concretions mimicking adenocarcinoma. Diagn Cytopathol 48(7):690-691, 2020. e-Pub 2020. PMID: 32294299.
- Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
- Al-Azzawi M, Misdraji J, van Velthuysen MF, Shia J, Taggart MW, Yantiss RK, Svrcek M, Carr N. Acellular mucin in pseudomyxoma peritonei of appendiceal origin: what is adequate sampling for histopathology?. J Clin Pathol 73(4):220-222, 2020. e-Pub 2020. PMID: 31611287.
- Sammour T, Malakorn S, Thampy R, Kaur H, Bednarski BK, Messick CA, Taggart MW, Chang GJ, You YN. Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation. Colorectal Dis 22(1):53-61, 2020. e-Pub 2020. PMID: 31356721.
- Delacruz RGC, Sandoval IT, Chang K, Miller BN, Reyes-Uribe L, Borras E, Lynch PM, Taggart MW, Hawk ET, Vilar E, Jones DA. Functional characterization of CNOT3 variants identified in familial adenomatous polyposis adenomas. Oncotarget 10(39):3939-3951, 2019. e-Pub 2019. PMID: 31231471.
- Chang K, Willis JA, Reumers J, Taggart MW, San Lucas FA, Thirumurthi S, Kanth P, Delker DA, Hagedorn CH, Lynch PM, Ellis LM, Hawk ET, Scheet PA, Kopetz S, Arts J, Guinney J, Dienstmann R, Vilar E. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Ann Oncol 29(10):2061-2067, 2018. e-Pub 2018. PMID: 30412224.
- Chang K, Taggart MW, Reyes-Uribe L, Borras E, Riquelme E, Barnett RM, Leoni G, San Lucas FA, Catanese MT, Mori F, Diodoro MG, You YN, Hawk ET, Roszik J, Scheet P, Kopetz S, Nicosia A, Scarselli E, Lynch PM, McAllister F, Vilar E. Immune Profiling of Premalignant Lesions in Patients With Lynch Syndrome. JAMA Oncol 4(8):1085-1092, 2018. e-Pub 2018. PMID: 29710228.
- Sagebiel TL, Mohamed A, Matamoros A, Taggart MW, Doamekpor F, Raghav KP, Mann GN, Mansfield PF, Eng C, Royal RE, Foo WC, Ensor JE, Fournier KF, Overman MJ. Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. Ann Surg Oncol 24(12):3667-3672, 2017. e-Pub 2017. PMID: 28831698.
- Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis. Clin Cancer Res 23(19):5936-5947, 2017. e-Pub 2017. PMID: 28645942.
- Borras E, Chang K, Pande M, Cuddy A, Bosch JL, Bannon SA, Mork ME, Rodriguez-Bigas MA, Taggart MW, Lynch PM, You YN, Vilar E. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila) 10(10):580-587, 2017. e-Pub 2017. PMID: 28765196.
- Grotz TE, Royal RE, Mansfield PF, Overman MJ, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Stratification of outcomes for mucinous appendiceal adenocarcinoma with peritoneal metastasis by histological grade. World J Gastrointest Oncol 9(9):354-362, 2017. e-Pub 2017. PMID: 28979717.
- Goldstein JB, Wu W, Borras E, Masand G, Cuddy A, Mork ME, Bannon SA, Lynch PM, Rodriguez-Bigas M, Taggart MW, Wu J, Scheet P, Kopetz S, You YN, Vilar E. Can Microsatellite Status of Colorectal Cancer Be Reliably Assessed after Neoadjuvant Therapy?. Clin Cancer Res 23(17):5246-5254, 2017. e-Pub 2017. PMID: 28522602.
- Grotz TE, Overman MJ, Eng C, Raghav KP, Royal RE, Mansfield PF, Mann GN, Robinson KA, Beaty KA, Rafeeq S, Matamoros A, Taggart MW, Fournier KF. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Moderately and Poorly Differentiated Appendiceal Adenocarcinoma: Survival Outcomes and Patient Selection. Ann Surg Oncol 24(9):2646-2654, 2017. e-Pub 2017. PMID: 28695394.
- Mork ME, Rodriguez A, Taggart MW, Rodriguez-Bigas MA, Lynch PM, Bannon SA, You YN, Vilar E. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer 16(3):357-361, 2017. e-Pub 2017. PMID: 28004223.
- Fournier K, Rafeeq S, Taggart MW, Kanaby P, Ning J, Chen HC, Overman M, Raghav K, Eng C, Mansfield P, Royal R. Low-grade appendiceal mucinous neoplasm of uncertain malignant potential (LAMN-UMP): prognostic factors and implications for treatment and follow-up. Ann Surg Oncol 24(1):187-193, 2017. e-Pub 2017. PMID: 27660258.
- Mork ME, Borras E, Taggart MW, Cuddy A, Bannon SA, You YN, Lynch PM, Ramirez PT, Rodriguez-Bigas MA, Vilar E. Identification of a novel PMS2 alteration c.505C>G (R169G) in trans with a PMS2 pathogenic mutation in a patient with constitutional mismatch repair deficiency. Fam Cancer 15(4):587-91, 2016. e-Pub 2016. PMID: 27017610.
- Borras E, San Lucas FA, Chang K, Zhou R, Masand G, Fowler J, Mork ME, You YN, Taggart MW, McAllister F, Jones DA, Davies GE, Edelmann W, Ehli EA, Lynch PM, Hawk ET, Capella G, Scheet P, Vilar E. Genomic Landscape of Colorectal Mucosa and Adenomas. Cancer Prev Res (Phila) 9(6):417-27, 2016. e-Pub 2016. PMID: 27221540.
- Cheah CY, Dsouza L, Taggart MW, Schlette EJ, Turturro F. Diffuse large B-cell lymphoma with microsatellite instability developing in the setting of Muir-Torre variant hereditary non-polyposis colon cancer. J Clin Pathol 68(9):755-7, 2015. e-Pub 2015. PMID: 26008772.
- Taggart MW, Hanna EY, Gidley P, Weber RS, Bell D. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol 19(3):154-6, 2015. e-Pub 2015. PMID: 25892663.
- Taggart MW, Abraham SC, Overman MJ, Mansfield PF, Rashid A. Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med 139(6):782-90, 2015. e-Pub 2015. PMID: 26030247.
- Mise Y, Kopetz S, Mehran RJ, Aloia TA, Conrad C, Brudvik KW, Taggart MW, Vauthey JN. Is complete liver resection without resection of synchronous lung metastases justified?. Ann Surg Oncol 22(5):1585-92, 2015. e-Pub 2015. PMID: 25373535.
- Overman MJ, Eng C, Raghav K, Matamoros A, Taggart MW, Foo WC, Fournier K. Challenges of efficacy assessments in pseudomyxoma peritonea. Oncologist 20(3):e3-4, 2015. e-Pub 2015. PMID: 25745054.
- Dineen S, Lynch PM, Rodriguez-Bigas MA, Bannon S, Taggart MW, Reeves C, Modaro C, Overman M, Chang GJ, Skibber JM, You YN. A prospective six sigma quality improvement trial to optimize universal screening for genetic syndrome among patients with youngo-onset colorectal cancer. J Natl Compr Canc Netw 13(7):865-872, 2015. e-Pub 2015. PMID: 26150580.
- Vilar E, Mork ME, Cuddy A, Borras E, Bannon SA, Taggart MW, Ying J, Broaddus RR, Luthra R, Rodriguez-Bigas MA, Lynch PM, You YQ. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet 207(10-12):495-502, 2014. e-Pub 2014. PMID: 25432668.
- Estrella JS, Taggart MW, Rashid A, Abraham SC. Low-grade neuroendocrine tumors arising in intestinal adenomas: evidence for alterations in the adenomatous polyposis coli/beta-catenin pathway. Hum Pathol 45(10):2051-8, 2014. e-Pub 2014. PMID: 25149552.
- Abraham SC, Taggart MW, Loftus EV Jr, Wu TT. Dysplasia-like epithelial atypia in ischemic bowel disease. Hum Pathol 45(7):1348-57, 2014. e-Pub 2014. PMID: 24946975.
- Borras E, Taggart MW, Lynch PM, Vilar E. Establishing a diagnostic road map for MUTYH-associated polyposis. Clin Cancer Res 20(5):1061-3, 2014. e-Pub 2014. PMID: 24486588.
- Ramineni M, Taggart MW, Rashid A, Abraham SC. Benign glandular downgrowth in gastric neuroendocrine neoplasms: a potential mimic of composite tumour. Histopathology 65(6):897-907, 2014. e-Pub 2014. PMID: 25041266.
- Hameed A, Taggart MW, Shaft MA. Adult Langerhans cell histiocytosis in a solitary colon polyp. JSM Clinic Case Rep 2(2):1023, 2014. e-Pub 2014.
- Estrella JS, Othman ML, Taggart MW, Hamilton SR, Curley SA, Rashid A, Abraham SC. Intrabiliary growth of liver metastases: clinicopathologic features, prevalence, and outcome. Am J Surg Pathol 37(10):1571-9, 2013. e-Pub 2013. PMID: 23797727.
- Taggart MW, Galbincea J, Mansfield PF, Fournier KF, Royal RE, Overman MJ, Rashid A, Abraham SC. High-level microsatellite instability in appendiceal carcinomas. Am J Surg Pathol 37(8):1192-200, 2013. e-Pub 2013. PMID: 23648460.
- Munoz J, Kumar VA, Hamilton J, Pasche LJ, Langford LA, Taggart MW, Kamiya-Matsuoka C, Tummala S, Moulder S, Kurzrock R. Posterior reversible encephalopathy syndrome: more than meets the eye. J Clin Oncol 31(20):e360-3, 2013. e-Pub 2013. PMID: 23733774.
- Overman MJ, Fournier K, Hu CY, Eng C, Taggart MW, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Ann Surg 257(6):1072-1078, 2013. e-Pub 2013. PMID: 23001080.
- Raghav KP, Shetty AV, Kazmi SM, Zhang N, Morris J, Taggart MW, Fournier K, Royal R, Mansfield P, Eng C, Wolff RA, Overman MJ. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist 18(12):1270-1277, 2013. e-Pub 2013. PMID: 24149137.
- Taggart MW, Rashid A, Ross WA, Abraham SC. Oesophageal hyperkeratosis: clinicopathological associations. Histopathology 63(4):463-473, 2013. e-Pub 2013. PMID: 23879628.
- Bilen MA, Taggart MW, Fournier K, Ellis LM, Mansfield PF, Eng C, Royal RE, Overman MJ. Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series. Acta Oncol 52(5):1044-1046, 2013. e-Pub 2013. PMID: 23020527.
- Agarwal A, Chang GJ, Hu CY, Taggart MW, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, Maru DM. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer 119(24):4231-4241, 2013. e-Pub 2013. PMID: 24089344.
- Lieu CH, Lambert LA, Wolff RA, Eng C, Zhang N, Wen S, Rafeeq S, Taggart MW, Fournier K, Royal R, Mansfield P, Overman MJ. Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Ann Oncol 23(3):652-658, 2012. e-Pub 2012. PMID: 21653683.
- Dorsey F, Taggart MW, Fisher WE. Image of the month. Pancreatic schwannoma. Arch Surg 145(9):913-914, 2010. e-Pub 2010. PMID: 20855766.
- Taggart MW, Craver R. Causes of death, determined by autopsy, in previously healthy (or near-healthy) children presenting to a children's hospital. Arch Pathol Lab Med 130(12):1780-1785, 2006. e-Pub 2006. PMID: 17149950.
- Greer RW, Taggart MW, Sartin BW, Angelica NJ, Johnson GM, Pappas ND, Newman WP, Glancy DL. Giant cell myocarditis presenting as rapidly progressive congestive heart failure complicated by ventricular arrhythmias. J La State Med Soc 155(4):198-202; quiz 202, 2003. e-Pub 2003. PMID: 14506826.
Invited Articles
- Bednarski BK, Taggart M, Chang GJ. MDT-How it is important in rectal cancer. Abdom Radiol (NY) 48(9):2807-2813, 2023. e-Pub 2023. PMID: 37393382.
- Booth AL, Taggart MW, Ono Y, Gonzalez RS. From mixed hyperplastic/adenomatous polyp to sessile serrated lesion: a long and winding road for long and winding crypts. Arch Pathol Lab Med 145(10):1289-1296, 2021. e-Pub 2021. PMID: 33351878.
- Taggart MW, Rashid A. Pathology and immunohistochemistry of hereditary colorectal cancer. Seminars in Colon & Rectal Surgery 22:71-76, 2011. e-Pub 2011.
Review Articles
- Fanaeian, M, Yousef, M, Yousef, A, Foo, WC, Taggart, MW, Beaty, K, Scally, CP, Mansfield, PF, Fournier, KF, Helmink, BA, Shen, JY. Risk of relapse after surgical resection of localized appendiceal adenocarcinoma. Journal of Clinical Oncology 42:58, 2024. e-Pub 2024.
- Lee S, Kassam Z, Baheti AD, Hope TA, Chang KJ, Korngold EK, Taggart MW, Horvat N. Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel. Abdom Radiol (NY) 48(9):2792-2806, 2023. e-Pub 2023. PMID: 37145311.
- Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Liu H, Zhang J, Resetkova E, Wang WL, Ding Q, Huo L, Yoon E. Unusual staining of immunohistochemical markers PAX8 and CDX2 in breast carcinoma: a potential diagnostic pitfall. Hum Pathol 125:35-47, 2022. e-Pub 2022. PMID: 35417734.
- Virarkar M, Szklaruk J, Jensen CT, Taggart MW, Bhosale P. What's New in Hepatic Steatosis. Semin Ultrasound CT MR 42(4):405-415, 2021. e-Pub 2021. PMID: 34130852.
- Kaur H, Gabriel H, Taggart MW, Kang HC, Konishi T, Rauch GM, Krishnan S, Chang G. MRI staging in an evolving management paradigm for rectal cancer, from the AJR special series on cancer staging. AJR Am J Roentgenol 217(6):1282-1293, 2021. e-Pub 2021. PMID: 33949877.
- Virarkar M, Saleh M, Diab R, Taggart MW, Bhargava P, Bhosale P. Hepatic Hemangioendothelioma: an update. World J Gastrointest Oncol 12(3):248-266, 2020. e-Pub 2020. PMID: 32206176.
- Ganeshan DM, Paulson E, Tamm EP, Taggart MW, Balachandran A, Bhosale P. Solid pseudo-papillary tumors of the pancreas: current update. Abdom Imaging 38(6):1373-82, 2013. e-Pub 2013. PMID: 23775388.
- Kang HC, Menias CO, Gaballah AH, Shroff S, Taggart MW, Garg N, Elsayes KM. Beyond the GIST: mesenchymal tumors of the stomach. Radiographics 33(6):1673-1690, 2013. e-Pub 2013. PMID: 24108557.
Other Articles
- Kaur, H, Gabriel, H, Awiwi, M, Maheshwari, E, Lopes Vendrami, C, Konishi, T, Taggart, MW, Magnetta, M, Kelahan, LC, Lee, S Erratum for Anatomic Basis of Rectal Cancer Staging: Clarifying Controversies and Misconceptions. Radiographics : a review publication of the Radiological Society of North America, Inc 44(9):e249006, 2024. PMID: 39231042.
Abstracts
- Seldomridge, A, Chiang, Y, Mansfield, P, Song, Y, Taggart, M, Foo, W, Shen, JP, Fournier, K, Helmink, B. Clinical outcomes of high-grade appendiceal mucinous neoplasm. Society of Surgical Oncology Annual Meeting, 2025. e-Pub 2025.
- Fanaeian MM, Yousef M, Yousef A, Foo W, Taggart MW, Beaty K, Scally C, Mansfield P, Fournier K, Helmink B, Shen JP. Risk of Relapse after Surgical Resection of Localized Appendiceal Adenocarcinoma. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium 42:58-58, 2024. e-Pub 2024.
- Elzamly S, Al-Attar M, Taggart MW, Foo WC, Maru D, Chatterjee D. SMARCA4-Deficient Carcinoma of the Esophagus: Diagnostic Challenges SMARCA4-Deficient Carcinoma of the Esophagus: Diagnostic Challenges with Synaptophysin Expression and Therapeutic Implications. United States and Canadian Academy of Pathology Annual Meeting:S703, 2024. e-Pub 2024.
- Fallon EA, Melendez B, Singh B, Lazcano R, Ingram D, Wani K, Fong LW, Damania AV, Orellana V, Fanaeian M, Ajami NJ, Losh J, Lazar AJ, Raghav K, Shen J, Taggart M, Wargo JA, White MG, Helmink BA. Utilizing spatial transcriptomics to define potential biomarkers of immune checkpoint blockade in appendiceal cancer – a proof of concept pilot study. Society for Immunotherapy for Cancer 12(2):A99-A100, 2024. e-Pub 2024.
- Fanaeian MM, Yousef MMG, Yousef A, Taggart M, Foo W, Beaty K, Scally C, Mansfield PF, Fournier K, White MG, Helmink B, Shen J. Clinical outcomes and molecular characterization of appendiceal goblet cell adenocarcinoma in 414 patients. European Society for Medical Oncology 35(1):S94-S105, 2024. e-Pub 2024.
- Huey RW, Gandhi N, Helmink BA, Overman MJ, Malpica A, Estrella J, Taggart M, Allam J, Scally C, Mansfield PF, Matamoros A, Elliott A, VanderWalde A, Ma PC, Halmos B, Liu SV, Fournier KF, Singh Raghav KP. Real-world outcomes and molecular correlates of incorporating immunotherapy (IO) and bevacizumab (Bev) in treating patients with peritoneal mesothelioma (PM). ASCO Annual Meeting 42(16), 2024. e-Pub 2024.
- White MG, Bhutiani N, Helmink BA, Taggart MW, Foo WC, Mansfield PF, Fournier KF, Scally CP. Treatment Variation and Long-Term Outcomes of Low-Grade Appendiceal Neoplasms. Annals of Surgical Oncology - visual abstract 30(13):8176, 2023. e-Pub 2023.
- Chapman L, White MG, Willett A, Beaty K, Matamoros A, Taggart MW, Foo WC, Scally C, Mansfield P, Malpica A, Raghav K, Fournier KF. Neoadjuvant chemotherapy (NACT) in Malignant Peritoneal in (MPeM) Treated with Cytoreduction (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC). European Society of Surgical Pathology Meeting 49(2):e60, 2023. e-Pub 2023.
- Lenskaya V, Jian X, Foo WC, Abraham SC, Taggart MW, Swisher S, Ning J, Aung PP, Curry JL, Cho WC, Torres-Cabala CA, Ivan D, Prieto VG, Amaria RN, Tawbi HA, Nagarajan P. Primary Mucosal Melanoma of the Esophagus: Clinicopathologic and Molecular Analysis. United States and Canadian Academy of Pathology Annual Meeting, 2023. e-Pub 2023.
- Taherian M, Taggart MW, Maru D, Foo WC, Rashid A, Abraham SC, Chatterjee D. Clinicopathologic Features of Esophageal Adenocarcinomas with Enteroblastic Differentiation. United States and Canadian Academy of Pathology Annual Meeting, 2023. e-Pub 2023.
- Yousef AMG, Yousef MMG, Zeineddine MAA, Ito I, Chawdhury S, Gu Y, Knafl M, Jin J, Edelkamp P, Uppal A, Bhutiani N, Alfaro-Munoz K, Bota-Rabassedas N, Helminth B, White M, Taggart MW, Raghav KPS, Overman MJ, Fournier KF, Shen JP. Prognostic & Predictive Significance of Pre- and Post-operative Plasma Tumor Markers in Patients with Appendiceal Adenocarcinoma Undergoing Cytoreductive Surgery: Insights from a Single-center Study. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium, 2023. e-Pub 2023.
- Peacock O, Manisundaram N, Kim Y, Stanietzky N, Holliday EB, Dasari A, Taggart MW, Kaur H, Bednarski B, Konishi T. Magnetic Resonance Imaging (MRI) Directed Surgical Decision Making for Lateral Pelvic Lymph Node Dissection (LPLND) in Rectal Cancer after Total Neoadjuvant Therapy (TNT). American Surgical Association 142nd Annual Meeting, 2022. e-Pub 2022.
- Tat Tong Y, Foo WC, Rashid A, Waters R, Abraham S, Chatterjee D, Taggart MW. Defining Amphicrine Carcinoma of the Gastrointestinal Tract: A Single Institutional Experience. United States and Canadian Academy of Pathology Annual Meeting 33, 2022. e-Pub 2022.
- Agnes A, Peacock O, Manisundaram N, Konishi T, Bednarski BK, Taggart MW, Vikram R, Stanietzky N, You YQN, Chang G. Evaluation of the Learning-curve for Robotic Lateral Pelvic Lymph Node Dissection (LPLND) for the Treatment of Rectal Cancer in a Western Institution. European Society of Coloproctology Conference 24(Supple. 3):48-294, 2022. e-Pub 2022.
- Waters R, Malpica A, Mansfield P, Raghav K, Taggart MW. Unifocal Peritoneal Malignant Mesothelioma as Initial Presentation of Lynch Syndrome: A Case Report and Brief Review. American Society of Clinical Pathology Annual Meeting, 2022. e-Pub 2022.
- Shen J, Yousef A, Zeineddine FA, Zeineddine MA, Slack Tidwell R, Wolff R, Taggart MW, Uppal A, Rafeeq S, Mansfield K, Raghav M, Overman M, Fournier K. Outcomes of Randomized Crossover Trial of Systemic Chemotherapy in Patients with Low-Grade Mucinous Appendiceal Adenocarcinoma. European Society for Medical Oncology, 2022 World Congress on Gastrointestinal Cancer 33(S4):S336, 2022. e-Pub 2022.
- Uppal A, Helmink B, Grotz TE, Fournier K, Nguyen S, Taggart MW, JPYC S, Bednarski BK, You YN, Chang GJ. What is the risk for peritoneal recurrence in T4 colon cancers?. Society for Surgical Oncology Virtual International Conference on Surgical Cancer Care 28:pages 1-162, 2021. e-Pub 2021.
- Zhang HC, Eyada M, Taggart MW, Negrao M, Varghesa S, Wang L. Clinical Presentation, Treatment Strategies, and Chronic Sequelae of Immune Checkpoint Inhibitor-Mediated Cholangiopathy: a Case Study. American Gastroenterology Association Annual Scientific Meeting & Postgraduate Course 116:S1139, 2021. e-Pub 2021.
- Eyada M, Taggart MW, Wang L, Miller E, Zhang HC. Diagnosis and characteristics of immune checkpoint inhibitor-mediated cholangiopathy: a cases series; poster presentation,. American Gastroenterology Association - Digestive Disease Week Virtual Meeting 160(6):S-851-S-852, 2021. e-Pub 2021.
- Zhang HC, Taggart MW, Miller E, Fossella F, Wang L. Extrahepatic Biliary Sequelae in Immune Checkpoint Inhibitor-Mediated Cholangiohepatitis: Urgent Unmet Need for Early Effective Treatment. American Gastroenterology Association Annual Scientific Meeting & Postgraduate Course 116:S1140, 2021. e-Pub 2021.
- Reyes-Uribe L, Evans K, Kinnison J, Sepeda VO, Weber DM, Moskowitz J, Mork ME, Taggart MW, Thirumurthi S, Rodriguez-Bigas MA, Lynch PM, You YN, Vilar E. Colorectal cancer surveillance outcomes from an institutional longitudinal cohort of lymph syndrome patients?. Collaborative Group of the Americas on Inherited Gastrointestinal Cancer, Virtual Annual Meeting, 2020. e-Pub 2020.
- Reyes-Ruribe, Wu W, Gelincik O, Bommi PV, Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P, Samadder NJ, Mork ME, Taggart MW, Milne GL, Marnett LJ, Vornik L, Liu DD, Revuela M, Chang K, You YN, Kopelovich L, Wistuba IV, Lee JJ, Sei S, Shoemaker PH, Szabo E, Richmond E, Umar A, Perioff M, Brown PH, Lipkin SM, Vilar E. Naproxen chemoprevention promotes immune activation in lynch syndrome colorectal mucosa. American Assocation for Cancer Research Virtual Annual Meeting/Cancer Research 80(16 Suppl): Abstract nr CT111), 2020. e-Pub 2020.
- Peacock O, Limvorapitak T, Hu CY, Bednarski BK, Taggart MW, Dasari A, Kopetz S, Holiday EB, Das P, You YN, Chang GJ. Improving the AJCC/TMN staging classification for colorectal cancer: The prognostic impact of tumour deposits. American Society of Clinical Oncology Virtual Annual Meeting 38:(suppl; abstr 4012), 2020. e-Pub 2020.
- Dhingra S, Heredia MLM, Taggart MW, Foo WC, Rashid A, May SB, Wang H. Inter-observer variability and challenges in intraoperative assessment of pancreatic margins in resection specimens. United States and Canadian Academy of Pathology Annual Meeting 100:1641, 2020. e-Pub 2020.
- Peacock O, Limvorapitak T, Bednarski B, Kaur H, Holiday E, Dean E, Taggart MW, Chang G. Robotic lateral pelvic lymph node dissection after chemoradiation for rectal cancer: A western perspective. American Society of Colon and Rectal Surgeons Annual Scientific Meeting 63(6):e87-e468, 2020. e-Pub 2020.
- Hwang KP, Wang X, Ernst RD, Palquist SM, Lebel M, Rauch G, Chang GJ, Messick C, Taggart MW, Bayram E, Ma J, Kaur H. Deep learning based image reconstruction for T2-weighted rectal cancer imaging. International Society for Magnetic Resonance in Imaging, 2020. e-Pub 2020.
- Lombardo JL, Taggart MW, Rashid A. Mast cell concentrations correlate with hepatic fibrosis in cancer patients. Experimental Biology Annual Meeting(34 S1), 2020. e-Pub 2020.
- Ibarra Rovira J, Thirumurthi S, Vickram R, Taggart MW, Naing A. Role of CT scans of abdomen and pelvis in management of patients with immunotherapy-induced colitis. Society for Immunotherapy of Cancer Virtual Annual Meeting, 2020. e-Pub 2020.
- Lee A, Chiang Y, Raghav K, Overman M, Eng C, Taggart MW, Feig B, Fournier K. Impact of tumor grade and extent of lymphadenectomy on survival for appendix cancer. Society of Surgical Oncology Annual Cancer Symposium 26:224, 2019. e-Pub 2019.
- Willis J, Mork ME, Chang K, Kinnison J, Rodriguez-Bigas MA, Thirumurthi S, Borras E, Taggart MW, Lynch PM, You YN, Vilar Sanchez E. Exploring the genetic basis of lynch-like syndrome through paired germline and tumor exome sequencing. American Society of Clinical Oncology Annual Meeting 37:(suppl; abstr 3592), 2019. e-Pub 2019.
- Jacome A, Raghav K, Shaw KR, Fournier K, Royal R, Taggart MW, Foo T, Matamoros A, Ahmed S, Guerra JL, Overman MJ, Eng C. Prognostic value of genetic mutations (GM) on overall survival in appendiceal adenocarcinoma (AA). American Society of Clinical Oncology Gastrointestinal Cancers Symposium 37(suppl 4; abstr 554), 2019. e-Pub 2019.
- Scally CP, Robinson KA, Rafeeq S, Raghav K, Eng C, Overman M, Foo T, Taggart MW, Mansfield PF, Royal RE, Fournier KF. Prognostic significance of acellular mucin in patients undergoing cytoreductive surgery and HIPEC (CRS/HIPEC) for appendiceal neoplasm. Society of Surgical Oncology Annual Cancer Symposium 26:224, 2019. e-Pub 2019.
- Meeta RP, Loree JM, Taggart MW, Malpica A, Matamoros A, Kopetz S, Varadhachary GR, Fournier KF, Royal RE, Raghav KPS. Malignant peritoneal mesothelioma: clinicopathological features, prognostic factors, and survival outcomes. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, 36(suppl 4S; absr 650), 2018. e-Pub 2018.
- Dartigues P, Van Velthuysen L, Carr N, Bibeau F, Bradley R, Geisinger K, Gui X, Isaac S, Misdraji J, Pai R, Shia J, Taggart MW, Yantiss R. Standardization of classification of PMP does not warrant standardization of interpretation: identifying the problem areas. Impact on the treatment strategy. 11th International Workshop on Peritoneal Surface Malignancy(Special Suppl, ppsA6-sA463), 2018. e-Pub 2018.
- Kazemimood R, Foo WC, Abraham S, Rashid A, Taggart MW. Updated American Joint Commission on Cancer Staging for ileal neuroendocrine tumors predicts recurrence-free interval. United States and Canadian Academy of Pathology Annual Meeting 98:274, 2018. e-Pub 2018.
- Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Huo L. Unusual Expression of Immunohistochemical Markers PAX8 and CDX2 in Breast Cancer. United States and Canadian Academy of Pathology Annual Meeting 98:294-295, 2018. e-Pub 2018.
- Van Velthuysen MF, Carr NJ, Bibeau F, Bradley RF, Dartigues P, Geisinger KR, Gui X, Isaac S, Misdraji J, Pai RK, Shia J, Taggart MW, Yantiss RK. Grading of PMP: identifying the problem areas. European Congress of Pathology, 2018. e-Pub 2018.
- Patel VR, Samdani RT, Abraham S, Estrella J, Taggart MW, Tan D, Wang H, Rashid A, Foo WC, Maru D. Clinicopathologic predictors of long-term responders to trastuzumab-based therapy in stage IV esophageal adenocarcinoma. United States and Canadian Academy of Pathology Annual Meeting 98:29295, 2018. e-Pub 2018.
- Shen T, Zhao J, Zhao M, Taggart MW, Ramalingam P, Gong Y, Wu Y, Huo L. Unusual expression of immunohistochemical markers PAX8 and CDX2 in breast cancer. United States and Canadian Academy of Pathology Annual Meeting 98:105, 2018. e-Pub 2018.
- Nickerson P, Chang G, Bednarski B, Rodriguez-Bigas M, Skibber J, You N, Taggart MW, Messick CA. Extramammary Paget’s disease: time for a change in management?. American Society of Colon and Rectal Surgeons Annual Meeting 63(6):e39-e40, 2018. e-Pub 2018.
- Zhang HC, Taggart MW, Blechacz TM. Gastrointestinal bleeding from metastatic angiosarcoma identified in the gastrointestinal tract. American College of Gastroenterology Annual Meeting, 2017. e-Pub 2017.
- Foo WC, Overman M, Vilar Sanchez E, Abraham S, Taggart MW. High level microsatellite instability in appendiceal carcinoma. United States and Canadian Academy of Pathology Annual Meeting, 2017. e-Pub 2017.
- Friedman K, Foo WC, Abraham SC, Rashid A, Taggart MW. Appendiceal goblet cell carcinoid tumor; findings after definitive resection. United States and Canadian Academy of Pathology 96:172A, 2016. e-Pub 2016.
- Ronquillo NR, Taggart MW, Foo WC. Completion resections in LAMN with extra-appendiceal mucin and appendiceal margin involvement. United States and Canadian Academy of Pathology 96:196A, 2016. e-Pub 2016.
- Agarwal A, Correa AM, Wang H, Maru D, Tan D, Abraham SC, Taggart MW, Estrella JS, Food WC, Hofstetter WL, Rashid A. Prospectively reported histologic tumor viability score and factors predicting long term survival in patients treated with trimodality therapy for primary esophageal adenocarcinoma. United States and Canadian Academy of Pathology 96:159A, 2016. e-Pub 2016.
- Shin US, You N, Price BA, Rodriguez-Bigas MA, Skibber JM, Maru DM, Taggart MW, Kopetz S, Eng C, Minsky BD, Das P, Krishnan S, Change GJ. Is the neutrophil-lymphocyte ratio (NLR) a predictive and prognostic factor in rectal cancer patients treated with neoadjuvant chemoradiation (nCRT)?. Association of Clinical Oncology Annual Meeting 34, 2016. e-Pub 2016.
- Jedrzkiewic J, Foo WC, Mansfield P, Overman M, Rafeeq S, Rashid A, Taggart MW. Conventional colonic-type adenocarcinoma of the appendix: clinicopathologic comparison with cecal adenocarcinomas. United States and Canadian Academy of Pathology 96:176A, 2016. e-Pub 2016.
- Lee SM, Taggart MW, Maru D, Abraham SC. Adenocarcinoma arising in atrophic autoimmune pangastritis confirmation of its neoplastic potential; poster presentation. United States and Canadian Academy of Pathology Annual Meeting 95:173A-174A, 2015. e-Pub 2015.
- Agarwal A, Tan D, Abraham S, Taggart MW, Wang H, Estrella JS, Zhang M, Rashid A, Maru D. Retrospective study of clinicopathologic features and patient outcome of primary adenosquamous carcinoma of the esophagus. United States and Canadian Academy of Pathology Annual Meeting 95:144A, 2015. e-Pub 2015.
- Morani A, Kaur H, Vikram R, You Y, Taggart MW, Chang G, Ernst R. Interobserver variability in interpretation of high resolution MRI of primary rectal cancer. Radiological Society of North American Annual Meeting, 2015. e-Pub 2015.
- Huba M, Taggart MW, Abraham. Metastatic gastrointestinal neuroendocrine tumors: problematic issues in diagnosis and grading; poster presentation,. Digestive Disease Week 5(146):S-212, 2014. e-Pub 2014.
- Overman MJ, George B, Taggart MW, Eng C, Royal RE, Wolff RA, Mansfield PF, Fournier KF. The natural history and role of surgical reduction and systemic chemotherapy in high-grade mucinous adenocarcinomas of the appendix. Association of Clinical Oncology - Gastrointestinal Cancers Symposium, 2014. e-Pub 2014.
- Kaur H, Taggart MW, Shin S, Ernst RD, Loyer EM, Aloia TA. Atypical imaging presentations of focal nodular hyperplasia with radiologic pathologic correlation (Certificate of Merit award). Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
- Sagebiel TL, MD, Bhosale PR, Fournier KF, Taggart MW, Matamoros A. Appendiceal Cancer: an update on pathology, imaging and therapy (Certificate of Merit award). Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
- Vilar E, Wu W, Bhatia G, Cuddy A, Mork ME, Bannon SA, Lynch PM, Rodriguez-Bigas MA, Taggart MW, You YN. Can microsatellite status of colorectal cancer (CRC) be reliably assessed after neoadjuvant therapy?. American Society of Clinical Oncology Annual Meeting 31(15_Suppl):1525, 2013. e-Pub 2013.
- Beaty K, Royal R, Fournier K, Taggart MW, Overman M Phillips J, Rafeeq S, Mansfield P, Wolff RA, Eng C. Impact of multidisciplinary therapy on high-grade appendiceal adenocarcinoma (AA). American Society of Clinical Oncology Annual Meeting 31(15_Suppl):413A, 2013. e-Pub 2013.
- Overman MJ, George B, Taggart MW, Eng C, Royal RE, Wolff RA, Mansfield PF, Fournier KF. The natural history and role of surgical cytoreduction and systemic chemotherapy in high-grade mucinous adenocarcinomas of the appendix. Association of Clinical Oncology - Gastrointestinal Cancers Symposium 31(4_Suppl):199, 2013. e-Pub 2013.
- Taggart MW, Ross WA, Rashid A, Abraham SC. Esophageal squamous dysplasia – clinical associations and follow-up. American Gastroenterology Association - Digestive Disease Week, Orlando FL 5(144):S-517, 2013. e-Pub 2013.
- Ganeshan DM, Kundra V, Taggart MW, Barlow JM, Bruining D, Hansel S, Pruthi S, Joel G Fletcher JG. Small bowel carcinoid tumors: finding them before they get to the mesentery and liver. Radiological Society of North America Annual Meeting, 2013. e-Pub 2013.
- Agarwal A, Chang G, Hu YC, Taggart MW, Rashid A, Kopetz S, Maru D. Residual tumor cell burden in rectal cancer: a new method of assessing pathologic response to neoadjuvant therapy. United States and Canadian Academy of Pathology Annual Meeting 93:141A, 2013. e-Pub 2013.
- Ramineni M, Taggart MW, Abraham SC. Benign epithelial downgrowth in gastric carcinoid tumors: a potential diagnostic pitfall. United States and Canadian Academy of Pathology Annual Meeting 93:173A-174A, 2013. e-Pub 2013.
- Taggart MW, Foo WC, Abraham SC. Duplication of molecular testing at a tertiary care oncology center. United States and Canadian Academy of Pathology Annual Meeting 93:486A-487A, 2013. e-Pub 2013.
- Shroff S, Taggart MW, Abraham SC, Rashid A. Intralymphatic tumor in duodenal biopsies: clinicopathologic features. United States and Canadian Academy of Pathology Annual Meeting 93:180A, 2013. e-Pub 2013.
- Raghav KP, Kazmi SM, Shetty AV, Taggart MW, Fournier KF, Royal RE, Mansfield PF, Eng C, Wolff RA, Overman MJ. Prognostic and predictive effect of COX-2 expression in appendiceal adenocarcinoma; poster presentation. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium 30(Suppl 4; abstr 526), 2012. e-Pub 2012.
- Raghav KPS, Ali Kazmi SM, Shetty AV, Taggart MW, Fournier KF, Royal RE, Mansfield PF, Eng C, Wolff RA, Overman MJ. Uncovering the clinicopathological and mutational profile of appendiceal adenocarcinomas. Association of Clinical Oncology - Gastrointestinal Cancers Symposium 30(4_Suppl):526, 2012. e-Pub 2012.
- Vadyala V, Krishna S, Walker L, Taggart MW, Abraham S, Rashid A, Stroehlein JR, Lynch P, Raju G. High synchronous polyp burden in patients with ≥ 1cm colon polyps; San Diego, CA. American Society for Gastrointestinal Endoscopy - Digestive Disease Week 75(4):AB280-AB281, 2012. e-Pub 2012.
- Estrella JS, Taggart MW, Rashid A, Abraham SC. Low grade neuroendocrine tumors arising in intestinal adenomas. United States and Canadian Academy of Pathology 92(160A), 2012. e-Pub 2012.
- Kaur H, Uribe E, Loyer EM, Ernest RD, Taggart MW, Aloia T, Jensen C, Marcal L, Choi H. Strengths and limitations of extravascular and liver specific contrast agents in the evaluation of liver lesions (Certificate of Merit Award). Radiologic Society of North America Annual Meeting, 2012. e-Pub 2012.
- Foo WC, Taggart MW, Abraham SC. Muscularis mucosae duplication and musculo-fibrous anomalies in squamous dysplasia of the esophagus. International Association of Pathology Scientific Meeting 61:79-80, 2012. e-Pub 2012.
- Hyngstrom JR, Rodriguez-Bigas MA, Chang GJ, Taggart MW, Skibber JM, Feig BW, You YN. Microsatellite high colorectal cancer: does the underlying mechanism for instability matter?. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium 30(4_Suppl):575, 2012. e-Pub 2012.
- Overman MJ, Fournier KF, Huc Y, Wolff RA, Eng C, Taggart MW, Royal RE, Mansfield PF, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histologic grade; poster presentation. American Society of Clinical Oncology - Gastrointestinal Cancers Symposium 30(Suppl 4; abstr 402), 2012. e-Pub 2012.
- You YN, Bannon S, Taggart MW, Reeves C, Modaro C, Skibber J, Lynch PM. Toward universal testing for hereditary non-polyposis colorectal cancer (HNPCC) syndrome in young patients with colorectal cancer: a quality improvement initiative. American Gastroenterological Association - Digestive Disease Week 142(5):S-220, 2012. e-Pub 2012.
- Shroff S, Taggart MW, Rashid A, Mounajjed T, Wu TT, Abraham S. Gastric chief cell adenomas: proposal for a new entity. United States and Canadian Academy of Pathology Annual Meeting 92:180A, 2012. e-Pub 2012.
- Zhao Q, Taggart MW, Abraham S. Giant and small cavernous hemangiomas of the liver. United States and Canadian Academy of Pathology 92:427A, 2012. e-Pub 2012.
- Taggart MW, Rashid A, Estrella JS, Abraham SC. Serrated polyps of the extracolonic gastrointestinal tract. United States and Canadian Academy of Pathology 92:182A, 2012. e-Pub 2012.
- Fournier K, Royal R, Rafeeq S, Eng C, Overman M, Taggart MW, Sagebiel T, Matamoros A, Mansfield P. Impact of body mass index on outcome of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Society of Surgical Oncology Annual Cancer Symposium 18 (Suppl 1):S103-S104, 2011. e-Pub 2011.
- Fournier KF, Royal R, Lambert LA, Taggart MW, Rafeeq S, Mansfield PF. Mucinous appendiceal tumors of uncertain malignant potential (UMP): prognostic factors and implications of treatment and follow-up. American Society of Clinical Oncology Gastrointestinal Cancer Symposium 29(4_suppl):372, 2011. e-Pub 2011.
- Estrella J, Wang H, Taggart MW, Abraham S, Rashid A. Immunohistochemical expression of progesterone receptor in neuroendocrine tumors: expression is present predominately in well-differentiated pancreatic endocrine neoplasms; poster presentation. United States and Canadian Academy of Pathology Annual Meeting 90:353A-354A, 2010. e-Pub 2010.
- Taggart MW, Rashid A, Abraham SC. Esophageal leukoplakia: risk factors and relationship to squamous neoplasia; poster presentation. United States and Canadian Academy of Pathology Annual Meeting 90:170A, 2010. e-Pub 2010.
- Feng X, Taggart MW, Corley L, Wang H, Hamilton SR, Rashid A. Nucleolin expression in colorectal adenocarcinoma: higher nucleolin expression is associated with better prognosis in stage iii colorectal cancers; poster presentation;. United States and Canadian Academy of Pathology Annual Meeting 89:129-A, 2009. e-Pub 2009.
- Taggart MW, Wang H, Maru DM, Tan D, Rashid A. Appendiceal mixed carcinoid-adenocarcinomas share better prognosis associated with goblet cell carcinoid tumors. United States and Canadian Academy of Pathology Annual Meeting 88:137A, 2008. e-Pub 2008.
- Taggart MW, Chirieac LR, Rashid A, Hamilton SR. Nucleolar expression of catalytic subunit of human telomerase reverse transcriptase (Htert) is associated with better survival in patients with stage iii colon cancer; poster presentation. United States and Canadian Academy of Pathology Annual Meeting 87:131A-131A, 2007. e-Pub 2007.
Book Chapters
- Taggart, MW. Anus and Perianal Skin. In: Grossing, Staging, and Reporting; An Integrated Manual of Modern Surgical Pathology. College of American Pathologists (CAP), 46-50, 2021.
- Taggart, MW. Appendix. In: Grossing, Staging, and Reporting; An Integrated Manual of Modern Surgical Pathology. College of American Pathologists (CAP), 51-57, 2021.
- Taggart, MW. Colon and Rectum. In: Grossing, Staging, and Reporting; An Integrated Manual of Modern Surgical Pathology. College of American Pathologists, 58-67, 2021.
- Taggart MW, Foo WC, Lee SM. Tumors of the Gastrointestinal System. In: In: Oncologic Surgical Pathology. Springer International Publishing, 691-870, 2020.
- Dineen SP, Taggart MW, Royal RE, Mansfield P, Fournier KF. Treatment Considerations for High-Grade Appendiceal Adenocarcinoma. In: Intraperitoneal Cancer Therapy: Principles and Practice. CRC Press; Pap/PSC Edition, 283-291, 2016.
Letters to the Editor
- Arango NP, Nishioka Y, Velasco J, Mahvash A, Mehran RJ, Wang LS, Taggart MW, Vauthey JN, Odisio BC. Involution of Hepatocellular Neoplasm after Embolization of a Portosystemic Vascular Shunt in an Adult with Abernethy Type II Malformation. J Vasc Interv Radiol 32: 1391-1393, 2021.
- Raghav KP, Taggart MW, Fournier KF, Overman MJ. Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity?. J Am Coll Surg 212: 906; author reply 907, 2011.
Patient Reviews
CV information above last modified March 24, 2026